Plasmodium — LLMpedia

Plasmodium
Image by Ute Frevert; false color by Margaret Shear. · CC BY 2.5 · source
Name	Plasmodium
Domain	Eukaryota
Phylum	Apicomplexa
Class	Aconoidasida
Order	Haemosporida
Family	Plasmodiidae
Genus	Plasmodium

Contents

Plasmodium is a genus of parasitic protozoa responsible for malaria in humans and other vertebrates. First described in the late 19th century during investigations by researchers associated with Royal Society, Pasteur Institute, Wellcome Trust, and field campaigns in Gabon, India, and Italy, the genus includes species that cycle between dipteran vectors and vertebrate hosts. Research from institutions such as London School of Hygiene and Tropical Medicine, Centers for Disease Control and Prevention, World Health Organization, and Bill & Melinda Gates Foundation has shaped modern control strategies.

Taxonomy and species diversity

The genus is classified within the phylum Apicomplexa and has been revised through work at Smithsonian Institution, Natural History Museum, London, Harvard University, and molecular labs at Sanger Institute and Max Planck Institute. Well-known human pathogens include species described by researchers associated with Gorgas Memorial Laboratory and Rockefeller Foundation teams: those historically linked to outbreaks in Panama, Nigeria, Brazil, and Papua New Guinea. Comparative studies involving specimens from Berlin, Tokyo, Moscow, Cape Town, and Sydney have documented dozens of species infecting mammals, birds, and reptiles, discussed in monographs circulated at Royal Society of Tropical Medicine and Hygiene meetings. Major taxonomic revisions have been published in journals from Cambridge University Press, Nature Publishing Group, Elsevier, and collections curated at British Museum.

Transmission cycles were elucidated through experiments by investigators affiliated with London School of Hygiene and Tropical Medicine, Rockefeller Foundation, Walter Reed Army Institute of Research, and expeditions to Ghana, Senegal, Thailand, and Venezuela. The parasite alternates between arthropod vectors such as species studied at Institut Pasteur field sites in Hanoi and vertebrate hosts monitored by teams from Centers for Disease Control and Prevention and Johns Hopkins University. Work by entomologists linked to London School of Hygiene and Tropical Medicine and University of Oxford clarified vector competence in genera investigated during colonial-era campaigns in India and Kenya. Transmission dynamics have been modeled in collaborations with researchers at Imperial College London, Massachusetts Institute of Technology, Princeton University, and University of California, San Francisco.

Microscopy and imaging of stages were advanced in laboratories at Max Planck Institute for Biophysical Chemistry, Cold Spring Harbor Laboratory, Harvard Medical School, and University of Cambridge. Ultrastructural analyses using techniques refined at Karolinska Institutet and European Molecular Biology Laboratory revealed apical complex components described in symposia at European Society for Molecular Biology. Molecular pathways have been mapped in projects funded by Wellcome Trust and published through collaborations with Broad Institute and Howard Hughes Medical Institute. Proteins implicated in invasion and egress were characterized in structural studies conducted at facilities like Diamond Light Source and Rutherford Appleton Laboratory.

Clinical features were characterized in cohorts studied at Mayo Clinic, Oxford University Hospitals, Kenya Medical Research Institute, and Malaria Research and Reference Reagent Resource Center. Severe disease phenotypes documented during epidemics in Gambia, Sierra Leone, Ethiopia, and Cambodia informed guidelines produced by World Health Organization and operational plans by Médecins Sans Frontières and UNICEF. Research into host immune responses included contributions from teams at University of Oxford, Harvard School of Public Health, National Institutes of Health, and Pasteur Institute units in Dakar and Lima.

Diagnostic methods evolved through innovations at Centers for Disease Control and Prevention, Foundation for Innovative New Diagnostics, Imperial College London, and University of Washington. Rapid diagnostic tests and microscopy protocols were validated in multicenter trials coordinated by World Health Organization and implemented in programs supported by Global Fund and Bill & Melinda Gates Foundation. Antimalarial chemotherapy history involves milestones associated with Rockefeller Foundation expeditions, clinical trials at Johns Hopkins University, and drug discovery at GlaxoSmithKline, Novartis, and Pfizer. Resistance monitoring programs run by World Health Organization and regional networks in Southeast Asia and Sub-Saharan Africa track efficacy of regimens recommended by panels connected to National Institutes of Health and European Medicines Agency.

Ecological and evolutionary studies drawing on fieldwork in Madagascar, Galápagos Islands, Borneo, and Amazon Basin have been conducted by teams from Smithsonian Tropical Research Institute, University of Queensland, University of California, Berkeley, and Duke University. Phylogenetic analyses using data from sequencing centers at Sanger Institute, Broad Institute, and Cold Spring Harbor Laboratory revealed host-switching events discussed at conferences hosted by Royal Society and American Society of Microbiology. Conservation concerns involving endangered hosts were addressed in coordination with World Wildlife Fund and researchers at Zoological Society of London.